Salivary gland carcinoma treated with concomitant chemoradiation with intraarterial cisplatin and docetaxel
- 31 October 2006
- journal article
- case report
- Published by Springer Science and Business Media LLC in International Journal of Clinical Oncology
- Vol. 11 (5), 403-406
- https://doi.org/10.1007/s10147-006-0587-0
Abstract
Malignant neoplasms of the salivary gland are uncommon entities in which surgical resection of the primary lesion has been accepted as a standard therapeutic option. The efficacy of radiation and systemic chemotherapy has been limited for patients with recurrent, metastatic, or unresectable disease because of unfavorable response rates and the short duration of the response. We treated one patient with recurrent adenoid cystic carcinoma arising from the sublingual gland and one patient with primary adenocarcinoma arising from the parotid gland with transfemoral intraarterial chemotherapy, based on full-dose cisplatin and docetaxel and concurrent external-beam radiotherapy. The doses of cisplatin and docetaxel in the two patients were 80–100 mg/m2 and 10–15 mg/m2, respectively. Docetaxel was infused first, followed by cisplatin. Both patients obtained complete responses. Although complications such as mucositis, anorexia, neutropenia, and ischemic colitis were observed, they were well tolerated and manageable. The concomitant chemoradiotherapy of cisplatin and docetaxel seemed to be a practicable option for patients with recurrent and unresectable salivary gland carcinomas.Keywords
This publication has 16 references indexed in Scilit:
- Concurrent chemoradiotherapy with cisplatin and docetaxel for advanced head and neck cancer. A phase I study.2005
- Rapid superselective high-dose cisplatin infusion with concomitant radiotherapy for advanced head and neck cancerHead & Neck, 2004
- Docetaxel enhances the cytotoxicity of cisplatin to gastric cancer cells by modification of intracellular platinum metabolismCancer Science, 2004
- Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative groupHead & Neck, 2004
- Response to paclitaxel and carboplatin in metastatic salivary gland cancer: A case reportHead & Neck, 2002
- Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancerThe Lancet, 2000
- Malignant salivary tumors—analysis of prognostic factors and survivalHead & Neck Surgery, 1986
- Salivary neoplasms: Overview of a 35‐year experience with 2,807 patientsHead & Neck Surgery, 1986
- Intra-arterial Cisplatin Treatment of Adenoid Cystic CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1982
- Taxol stabilizes microtubules in mouse fibroblast cells.Proceedings of the National Academy of Sciences of the United States of America, 1980